GEVIMIS
Live / Registered — Madrid extension — notification from the International Bureau (as of 15 Jan 2021)
What this means for you
Registered since 30 Aug 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79184643
- Registration number
- 5029385
- Mark type
- Stylized text
- Filed
- 22 Jan 2016
- Published for opposition
- 14 Jun 2016
- Registered
- 30 Aug 2016
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; ] pharmaceutical products for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma ]
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 23 May 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 25 Oct 2020 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 24 Oct 2020 — DEATH OF INTERNATIONAL REGISTRATION
- 01 Nov 2019 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 01 Nov 2019 — DEATH OF INTERNATIONAL REGISTRATION
- 11 Jan 2018 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 26 Dec 2017 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Apr 2017 — LIMITATION FROM THE IB EXAMINED AND ENTERED
- 26 Apr 2017 — CORRECTION UNDER SECTION 7 - PROCESSED
- 26 Apr 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Apr 2017 — LIMITATION OF GOODS RECEIVED FROM IB
- 21 Oct 2016 — NOTIFICATION PROCESSED BY IB
- 03 Oct 2016 — FINAL DISPOSITION NOTICE SENT TO IB
- 03 Oct 2016 — FINAL DISPOSITION PROCESSED
- 29 Sept 2016 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB